Current Neuro-Oncology
Volume
24 Number 3
15 February 2022
Home > Publications > Current Neuro-Oncology > Volume 24, Year 2022 > Number 3, 15 February
Miller
KE, Cassady KA, Roth JC, Clements J, Schieffer KM, Leraas K,
Miller AR, Prasad N, Leavenworth JW, Aban IB, Whitley RJ,
Gillespie GY, Mardis ER, Markert JM.
Immune
Activity and Response Differences of Oncolytic Viral Therapy
in
Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB
Study.
Clin
Cancer Res. 2022 Feb 1;28(3):498-506∟.
doi: 10.1158/1078-0432.CCR-21-2636∟.
PMID: 35105718∟.
Interventional study. ˍ
Ng
S, Lemaitre AL, Moritz-Gasser S, Herbet G, Duffau H.
Recurrent
Low-Grade
Gliomas:
Does Reoperation Affect Neurocognitive Functioning?
Neurosurgery.
2022 Feb 1;90(2):221-232∟.
doi: 10.1227/NEU.0000000000001784∟.
PMID: 34995251∟.
Observational study˰ ˍ
Stoyanov
GS, Lyutfi E, Georgieva R, Georgiev R, Dzhenkov DL, Petkova L,
Ivanov BD, Kaprelyan A, Ghenev P.
Reclassification
of Glioblastoma Multiforme
According
to the 2021 World Health Organization Classification of Central
Nervous
System Tumors: A Single Institution Report and Practical
Significance.
Cureus.
2022 Feb 1;14(2):e21822∟.
doi: 10.7759/cureus.21822∟.
PMID: 35291535∟.
Observational study. ˍ
Arsene
DE, Milanesi E, Dobre M.
Viral
oncogenesis in tumours of the central nervous system: reality or
random association? A retrospective study on archived material.
J
Cell Mol Med. 2022 Feb 2∟.
doi: 10.1111/jcmm.17064∟.
PMID: 35112466∟.
Observational study. ˍ
Kobayashi
T, Nitta M, Shimizu K, Saito T, Tsuzuki S, Fukui A, Koriyama S,
Kuwano A, Komori T, Masui K, Maehara T, Kawamata T, Muragaki
Y.
Therapeutic
Options
for Recurrent Glioblastoma
-
Efficacy
of Talaporfin Sodium Mediated
Photodynamic
Therapy.
Pharmaceutics.
2022 Feb 2;14(2):353∟.
doi: 10.3390/pharmaceutics14020353∟.
PMID: 35214085∟.
Observational study. ˍ
Li
M, Huang W, Chen H, Jiang H, Yang C, Shen S, Cui Y, Dong G, Ren X,
Lin S.
T2/FLAIR
Abnormity Could be the Sign of Glioblastoma Dissemination.
Front
Neurol. 2022 Feb 2;13:819216∟.
doi: 10.3389/fneur.2022.819216∟.
PMID: 35185770∟.
Observational study. ˍ
Ronsley
R, Crowell C, Irvine M, Kang M, Goldman RD, Erker C, Cheng
S.
Impact
of
Time to Diagnosis on Morbidity and Survival in Children With
Malignant
Central
Nervous System Tumors.
J
Pediatr Hematol Oncol. 2022 Feb 4∟.
doi: 10.1097/MPH.0000000000002424∟.
PMID: 35129148∟.
Observational study˰ ˍ
Li
Y, Wang F, Li B.
Photodynamic
therapy during second surgery for recurrent
gliomas
improves survival.
Photodiagnosis
Photodyn Ther. 2022 Feb 6;38:102754∟.
doi: 10.1016/j.pdpdt.2022.102754∟.
PMID: 35139338∟.
Observational study. ˍ
Majzner
RG, Ramakrishna S, Yeom KW, Patel S, Chinnasamy H, Schultz LM,
Richards RM, Jiang L, Barsan V, Mancusi R, Geraghty AC, Good Z,
Mochizuki AY, Gillespie SM, Toland AMS, Mahdi J, Reschke A, Nie E,
Chau IJ, Rotiroti MC, Mount CW, Baggott C, Mavroukakis S, Egeler
E, Moon J, Erickson C, Green S, Kunicki M, Fujimoto M, Ehlinger Z,
Reynolds W, Kurra S, Warren KE, Prabhu S, Vogel H, Rasmussen L,
Cornell TT, Partap S, Fisher PG, Campen CJ, Filbin MG, Grant G,
Sahaf B, Davis KL, Feldman SA, Mackall CL, Monje M.
GD2-CAR
T cell therapy for H3K27M-mutated diffuse midline gliomas.
Nature.
2022 Feb 7∟.
doi: 10.1038/s41586-022-04489-4∟.
PMID: 35130560∟.
Interventional study˰ ˍ
Odia
Y, Cavalcante L, Safran H, Powell SF, Munster PN, Ma WW, Carneiro
BA, Bastos BR, Mikrut S, Mikrut W, Giles FJ, Sahebjam S.
Malignant
glioma subset
from
actuate 1801: Phase I/II study of 9-ING-41, GSK-3β inhibitor,
monotherapy or
combined with chemotherapy for refractory malignancies.
Neurooncol
Adv. 2022 Feb 7;4(1):vdac012∟.
doi: 10.1093/noajnl/vdac012∟.
PMID: 35402914∟.
Interventional study. ˍ
Maimaiti
B, Mijiti S, Jiang T, Xie Y, Zhao W, Cheng Y, Meng H.
Case
Report:
H3K27M-Mutant
Glioblastoma Simultaneously Present in the Brain and Long-Segment
Spinal
Cord Accompanied by Acute Pulmonary Embolism.
Front
Oncol. 2022 Feb 8;11:763854∟.
doi: 10.3389/fonc.2021.763854∟.
PMID: 35211394∟.
Case report. ˍ
Moore
KJ, Moertel CL, Williams LA.
Young
adult males have worse survival than
females
that is largely independent of treatment received for many types
of central
nervous system tumors: A National Cancer Database
analysis.
Cancer.
2022 Feb 8;128(8):1616-1625∟.
doi: 10.1002/cncr.34120∟.
PMID: 35132626∟.
Observational study˰ ˍ
Ahn
S, Kim YI, Shin JY, Park JS, Yoo C, Lee YS, Hong YK, Jeun SS, Yang
SH.
Clinical
feasibility of modified procarbazine and lomustine chemotherapy
without
vincristine
as a salvage treatment for recurrent adult glioma.
Oncol
Lett. 2022 Feb 9;23(4):114∟.
doi: 10.3892/ol.2022.13234∟.
PMID: 35251345∟.
Observational study. ˍ
El
Rahal A, Cipriani D, Fung C, Hohenhaus M, Sveikata L, Straehle J,
Shah MJ, Heiland HD, Beck J, Schnell O.
Hydrocephalus
Shunting in Supratentorial
Glioblastoma:
Functional Outcomes and Management.
Front
Oncol. 2022 Feb 9;12:796105∟.
doi: 10.3389/fonc.2022.796105∟.
PMID: 35223477∟.
Observational study. ˍ
Hagel
C, Sloman V, Mynarek M, Petrasch K, Obrecht D, Kühl J,
Deinlein F, Schmid R, von Bueren AO, Friedrich C, Juhnke BO,
Gerber NU, Kwiecien R, Girschick H, Höller A, Zapf A, von
Hoff K, Rutkowski S.
Refining
M1 stage in
medulloblastoma:
criteria for cerebrospinal fluid cytology and implications for
improved
risk stratification from the HIT-2000 trial.
Eur
J Cancer. 2022 Feb 9;164:30-38∟.
doi: 10.1016/j.ejca.2021.12.032∟.
PMID: 35151105∟.
Observational study˰ ˍ
Uemura
S, Demizu Y, Hasegawa D, Fujikawa T, Inoue S, Nishimura A, Tojyo
R, Nakamura S, Kozaki A, Saito A, Kishimoto K, Ishida T, Mori T,
Koyama J, Kawamura A, Akasaka Y, Yoshida M, Fukumitsu N, Soejima
T, Kosaka Y.
The
comparison of
acute
toxicities associated with craniospinal irradiation between photon
beam therapy
and proton beam therapy in children with brain tumors.
Cancer
Med. 2022 Feb 9∟.
doi: 10.1002/cam4.4553∟.
PMID: 35137555∟.
Observational study. ˍ
Reiner
AS, Lobaugh SM, Gonen S, Diamond EL, Panageas KS.
A
Population-Based Study of Treatment and Survival in Older Glioma
Patients.
JNCI
Cancer Spectr. 2022 Feb 9;6(1):pkac010∟.
doi: 10.1093/jncics/pkac010∟.
PMID: 35699501∟.
Observational study. ˍ
Zaghloul
MS, Nasr A, Tolba M, Refaat A, Youssef A, Moseab A, Enayet A,
Arafa O, Maher E, Eldebawy E.
Hypofractionated
radiotherapy for Diffuse Intrinsic
Pontine
Glioma (DIPG): A non-inferiority prospective randomized study
including 253
children.
Int
J Radiat Oncol Biol Phys. 2022 Feb 9;113(2):360-368∟.
doi: 10.1016/j.ijrobp.2022.01.054∟.
PMID: 35150788∟.
Interventional study˰ ˍ
*
Yang
ZY, Wang XH.
Valproic
Acid Inhibits Glioma and Its Mechanisms.
J
Healthc Eng. 2022 Feb 10;2022:4985781∟.
doi: 10.1155/2022/4985781∟.
PMID: 35251569∟.
Laboratory investigation. ˍ
Liu
H, Chen Y, Qin X, Jin Z, Jiang Y, Wang Y.
Epidemiology
and Survival of
Patients
With Optic Pathway Gliomas: A Population-Based Analysis.
Front
Oncol. 2022 Feb 11;12:789856∟.
doi: 10.3389/fonc.2022.789856∟.
PMID: 35223473∟.
Observational study. ˍ
Metzger
S, Weiser A, Gerber NU, Otth M, Scheinemann K, Krayenbühl N,
Grotzer MA, Guerreiro Stucklin AS.
Central
nervous system tumors in children under 5 years of age: a report
on treatment burden, survival and long-term outcomes.
J
Neurooncol. 2022 Feb 11∟.
doi: 10.1007/s11060-022-03963-3∟.
PMID: 35147892∟.
Observational study. ˍ
Wang
L, Shao L, Li H, Yao K, Duan Z, Zhi C, Song S, Cheng Y, Wang F,
Wang W, Piao Y, Gui Q, Lu D, Qi X, Teng L.
Histone
H3.3 G34-mutant Diffuse Gliomas in Adults.
Am
J Surg Pathol. 2022 Feb 11;46(2):249-257∟.
doi: 10.1097/PAS.0000000000001781∟.
PMID: 34352809∟.
Observational study˰ ˍ
Ramírez
E, Jara N, Ferrada L, Salazar K, Martínez F, Oviedo MJ,
Tereszczuk J, Ramírez-Carbonell S, Vollmann A, Hau P,
Nualart F.
Glioblastoma
invasiveness and
collagen
secretion are enhanced by vitamin C.
Antioxid
Redox Signal. 2022 Feb 15∟.
doi: 10.1089/ars.2021.0089∟.
PMID: 35166128∟.
Laboratory investigation˰ ˍ